Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study
Fig 5
Survival analyses for myxoid change, fibrotic focus (FF), and a combination of myxoid change and fibrotic focus in patients without adjuvant chemotherapy.
(a) Kaplan–Meier curves for the overall survival (OS) and relapse-free survival (RFS) of patients without adjuvant chemotherapy. OS (left) and RFS (right) curves among myxoid change-positive (red line) and myxoid change-negative (blue line) patients. (b) OS (left) and RFS (right) curves among FF-positive (red line) and FF-negative (blue line) patients. (c) Overall survival (OS) (left) and relapse-free survival (RFS) (right) curves in myxoid change and FF-positive (red line) and myxoid change- and/or FF-negative (blue line) patients.